MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Free Cash Flow of $46.3 million for Q4 2025, up 289.1% on a YoY basis from $11.9 million in Q4 2024, and up 461.86% quarter-over-quarter from -$12.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Free Cash Flow (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Free Cash Flow for 9 years, with the latest figure at $46.3 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 289.1% year-over-year to $46.3 million; the trailing twelve-month figure through Dec 2025 stood at -$50.2 million (up 54.11% YoY), and the FY2025 full-year result was -$50.2 million, up 54.11% from the prior year.
- Free Cash Flow for Q4 2025 stood at $46.3 million, up from -$12.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $46.3 million in Q4 2025, with the low at -$46.0 million in Q1 2023.
- Historically, Free Cash Flow has averaged -$23.0 million across 5 years, with a median of -$26.3 million in 2021.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 552.84% — and 2025, when it soared 289.1%.
- MeiraGTx Holdings' Free Cash Flow stood at -$5.5 million in 2021, then plunged by 346.83% to -$24.8 million in 2022, then grew by 29.01% to -$17.6 million in 2023, then slumped by 39.35% to -$24.5 million in 2024, then soared by 289.1% to $46.3 million in 2025.
- The last three Free Cash Flow figures came in at $46.3 million (Q4 2025), -$12.8 million (Q3 2025), and -$45.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 46.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.32 Mn |
| Dec 31, 2025 | 46.32 Mn |
| Sep 30, 2025 | -12.80 Mn |
| Sep 30, 2025 | -12.80 Mn |
| Jun 30, 2025 | -45.21 Mn |
| Jun 30, 2025 | -45.21 Mn |
| Mar 31, 2025 | -38.54 Mn |
| Mar 31, 2025 | -38.54 Mn |
| Dec 31, 2024 | -24.49 Mn |
| Dec 31, 2024 | -24.49 Mn |
| Sep 30, 2024 | -25.75 Mn |
| Sep 30, 2024 | -25.75 Mn |
| Jun 30, 2024 | -20.79 Mn |
| Jun 30, 2024 | -20.79 Mn |
| Mar 31, 2024 | -38.42 Mn |
| Mar 31, 2024 | -38.42 Mn |
| Dec 31, 2023 | -17.58 Mn |
| Dec 31, 2023 | -17.58 Mn |
| Sep 30, 2023 | -27.98 Mn |
| Sep 30, 2023 | -27.98 Mn |